Vertex Pharmaceuticals, Inc. (VRTX)

476.90 +7.63 (+1.63%) USD  |  NASDAQ  |  Feb 20, 16:00
476.85 -0.05 (-0.01%) Pre-Market: 20:00
More

Vertex Pharmaceuticals Current Portion of Long Term Debt (Quarterly)

Current Portion of Long Term Debt (Quarterly) Chart

View Current Portion of Long Term Debt (Quarterly) for VRTX.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Current Portion of Long Term Debt (Quarterly) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Current Portion of Long Term Debt (Quarterly) Range, Past 5 Years

View Current Portion of Long Term Debt (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Current Portion of Long Term Debt (Quarterly) Benchmarks

View Current Portion of Long Term Debt (Quarterly) Benchmarks
Start Trial
Moderna, Inc. Upgrade
Gilead Sciences, Inc. --
Eli Lilly & Co. Upgrade
Merck & Co., Inc. --
Pfizer Inc. --